Research identifies key enzyme target to fight deadly brain cancers
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Rubi Pepper
Tislelizumab Approved for First-Line in ESCC
The US Food and Drug Administration has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing chemotherapy, for the first-line treatment...
